Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysis

Affiliations

• ¹ John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Tex.
• ² John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Tex; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
• ³ Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
• ⁴ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.
• ⁵ Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Tex.
• ⁶ Department of Dermatology, University of Texas Medical Branch, Galveston, Tex.
• ⁷ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: nicholas.gulati@mssm.edu.